TELA Bio (TELA) News Today $0.98 +0.04 (+4.15%) Closing price 04/11/2025 04:00 PM EasternExtended Trading$0.98 +0.00 (+0.20%) As of 04/11/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Canaccord Genuity Keeps Their Buy Rating on TELA Bio (TELA)April 9 at 6:28 PM | markets.businessinsider.comTELA Bio Expands OviTex PRS Line with Larger Surgical SizesApril 2, 2025 | msn.comTela Bio announces U.S. launch of larger sizes of OviTex PRSApril 1, 2025 | markets.businessinsider.comTELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive SurgeryApril 1, 2025 | markets.businessinsider.comPerkins Capital Management Inc. Has $2.74 Million Holdings in TELA Bio, Inc. (NASDAQ:TELA)Perkins Capital Management Inc. lifted its holdings in TELA Bio, Inc. (NASDAQ:TELA - Free Report) by 303.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 907,865 shares of the company's stock after purchasing aMarch 25, 2025 | marketbeat.comTELA BIO Earnings Results: $TELA Reports Quarterly EarningsMarch 23, 2025 | nasdaq.comTELA Bio Full Year 2024 Earnings: Revenues DisappointMarch 23, 2025 | finance.yahoo.comCanaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $7.00Canaccord Genuity Group dropped their price target on TELA Bio from $12.00 to $7.00 and set a "buy" rating on the stock in a research note on Friday.March 22, 2025 | marketbeat.comTELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | insidermonkey.comTELA Bio (NASDAQ:TELA) Rating Lowered to Neutral at Piper SandlerPiper Sandler lowered shares of TELA Bio from an "overweight" rating to a "neutral" rating and cut their price target for the stock from $5.00 to $2.00 in a report on Friday.March 22, 2025 | marketbeat.comTELA Bio, Inc.: TELA Bio Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 21, 2025 | finanznachrichten.deTela Bio price target lowered to $7 from $12 at Citizens JMPMarch 21, 2025 | markets.businessinsider.comTela Bio downgraded to Neutral from Overweight at Piper SandlerMarch 21, 2025 | markets.businessinsider.comTELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales TurnoverMarch 21, 2025 | finance.yahoo.comTela Bio slumps after Q4 miss as Piper Sandler downgradesMarch 21, 2025 | msn.comTELA Bio (NASDAQ:TELA) Releases Earnings Results, Beats Estimates By $0.01 EPSTELA Bio (NASDAQ:TELA - Get Free Report) issued its earnings results on Thursday. The company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.24) by $0.01. TELA Bio had a negative net margin of 60.49% and a negative return on equity of 556.18%.March 21, 2025 | marketbeat.comTela Bio sees Q1 revenue $17M-$18M, consensus $21.05MMarch 21, 2025 | markets.businessinsider.comTELA Bio shares plunge on Q4 revenue miss, weak guidanceMarch 21, 2025 | investing.comTELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategyMarch 21, 2025 | msn.comTELA Bio, Inc. (TELA) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comTELA Bio Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 20, 2025 | globenewswire.comRoyce & Associates LP Purchases New Holdings in TELA Bio, Inc. (NASDAQ:TELA)Royce & Associates LP purchased a new stake in shares of TELA Bio, Inc. (NASDAQ:TELA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,000,064 shares of the company's stock, valued at approximately $3,02March 20, 2025 | marketbeat.comShort Interest in TELA Bio, Inc. (NASDAQ:TELA) Declines By 15.9%TELA Bio, Inc. (NASDAQ:TELA - Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 467,800 shares, a drop of 15.9% from the February 13th total of 556,500 shares. Currently, 1.3% of the company's shares are short sold. Based on an average daily volume of 171,100 shares, the short-interest ratio is presently 2.7 days.March 19, 2025 | marketbeat.comTELA Bio (TELA) Receives a Buy from Lake StreetMarch 17, 2025 | markets.businessinsider.comTELA Bio (TELA) to Release Earnings on ThursdayTELA Bio (NASDAQ:TELA) will be releasing earnings after the market closes on Thursday, March 20, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=313095)March 13, 2025 | marketbeat.comTELA Bio (NASDAQ:TELA) Stock Price Down 3.1% - Should You Sell?TELA Bio (NASDAQ:TELA) Stock Price Down 3.1% - Time to Sell?March 1, 2025 | marketbeat.comTELA Bio to Announce Fourth Quarter and Full Year 2024 Financial ResultsFebruary 27, 2025 | globenewswire.comTELA Bio Announces Inducement Grants to Newly Hired EmployeesFebruary 23, 2025 | msn.comTELA Bio, Inc. (NASDAQ:TELA) Short Interest UpdateTELA Bio, Inc. (NASDAQ:TELA - Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 414,300 shares, an increase of 17.8% from the January 15th total of 351,600 shares. Based on an average daily volume of 186,200 shares, the short-interest ratio is presently 2.2 days.February 16, 2025 | marketbeat.comTELA Bio (NASDAQ:TELA) Shares Down 1.4% - Should You Sell?TELA Bio (NASDAQ:TELA) Shares Down 1.4% - What's Next?February 7, 2025 | marketbeat.comTELA Bio Grants Inducement Stock Units to New EmployeesJanuary 25, 2025 | msn.comTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)January 24, 2025 | globenewswire.comRetail investors account for 41% of TELA Bio, Inc.'s (NASDAQ:TELA) ownership, while institutions account for 28%January 12, 2025 | finance.yahoo.comLake Street Keeps Their Buy Rating on TELA Bio (TELA)January 8, 2025 | markets.businessinsider.comTELA Bio (NASDAQ:TELA) Stock Price Down 0.3% - Here's WhyTELA Bio (NASDAQ:TELA) Shares Down 0.3% - Time to Sell?December 31, 2024 | marketbeat.comTELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)December 13, 2024 | globenewswire.comThe past five years for TELA Bio (NASDAQ:TELA) investors has not been profitableDecember 1, 2024 | uk.finance.yahoo.comTELA Bio, Inc. (NASDAQ:TELA) Short Interest Down 29.8% in NovemberTELA Bio, Inc. (NASDAQ:TELA - Get Free Report) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 335,900 shares, a decline of 29.8% from the October 31st total of 478,700 shares. Based on an average trading volume of 223,100 shares, the days-to-cover ratio is presently 1.5 days.November 29, 2024 | marketbeat.comTELA Bio Set for Growth with Strategic Enhancements and Financial ImprovementsNovember 23, 2024 | markets.businessinsider.comTELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference!November 21, 2024 | msn.comTELA Bio to Participate in Piper Sandler’s 36th Annual Healthcare ConferenceNovember 20, 2024 | markets.businessinsider.comTELA Bio to Participate in Piper Sandler's 36th Annual Healthcare ConferenceNovember 19, 2024 | globenewswire.comTELA Bio’s Strong Financial Performance and Strategic Positioning Justify Buy RatingNovember 13, 2024 | markets.businessinsider.comTELA Bio, Inc. (NASDAQ:TELA) Sees Large Drop in Short InterestTELA Bio, Inc. (NASDAQ:TELA - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 478,700 shares, a decline of 68.9% from the October 15th total of 1,540,000 shares. Based on an average daily volume of 258,700 shares, the days-to-cover ratio is presently 1.9 days.November 12, 2024 | marketbeat.comTELA Bio Third Quarter 2024 Earnings: EPS Beats ExpectationsNovember 11, 2024 | finance.yahoo.comQ3 2024 TELA Bio Inc Earnings CallNovember 10, 2024 | finance.yahoo.comTELA Bio Reports Strong Revenue Growth in Q3 2024November 10, 2024 | msn.comTela Bio price target lowered to $5 from $8 at Piper SandlerNovember 10, 2024 | markets.businessinsider.comTELA Bio, Inc. (TELA) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comTELA Bio (NASDAQ:TELA) Price Target Lowered to $5.00 at Piper SandlerPiper Sandler decreased their target price on TELA Bio from $8.00 to $5.00 and set an "overweight" rating for the company in a research report on Friday.November 8, 2024 | marketbeat.com Remove Ads Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address TELA Media Mentions By Week TELA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TELA News Sentiment▼0.940.95▲Average Medical News Sentiment TELA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TELA Articles This Week▼22▲TELA Articles Average Week Remove Ads Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Profound Medical News Today Lucid Diagnostics News Today Perspective Therapeutics News Today Beauty Health News Today Sight Sciences News Today Neuronetics News Today Orchestra BioMed News Today InfuSystem News Today Anteris Technologies Global News Today Jin Medical International News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TELA) was last updated on 4/12/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThis almost killed Elon Musk (chilling details emerge)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredWARNING to All American InvestorsForget the headlines about the "trade war." This is where a real military showdown between China and the U....Behind the Markets | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TELA Stock Free TELA Stock Alerts